Join
Live feed
·
INSIDERFilingvia Quantisnow
Monte Rosa Therapeutics Inc. logo

Dunn Edmund sold $4,876 worth of shares (1,207 units at $4.04), decreasing direct ownership by 7% to 15,554 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
GLUE· Monte Rosa Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track GLUE (Monte Rosa Therapeutics Inc.) and more on Quantisnow.